A Prehabilitation Program in Patients with Breast Cancer Receiving Neoadjuvant Therapy to Minimize Musculoskeletal Postoperative Complications and Enhance Recovery (PREOPtimize): A Protocol for a Randomized Controlled Trial.
Anabel Casanovas-ÁlvarezSebio-García RaquelMagda CiendonesJordi CuarteroBlanca EstanyolJosep PadrósBárbara García-ValdecasasAgustí BarnadasJaume MasiàPublished in: Physical therapy (2023)
Prehabilitation for patients affected by breast cancer is rarely implemented in clinical practice. The results obtained with the PREOPtimize trial could show that prehabilitation is a feasible intervention for patients with breast cancer receiving neoadjuvant therapy that might enhance postoperative recovery of upper arm function as well as improve overall physical performance and health-related quality of life.
Keyphrases
- rectal cancer
- clinical practice
- end stage renal disease
- ejection fraction
- locally advanced
- lymph node
- chronic kidney disease
- newly diagnosed
- randomized controlled trial
- physical activity
- mental health
- squamous cell carcinoma
- prognostic factors
- peritoneal dialysis
- stem cells
- radiation therapy
- mesenchymal stem cells
- bone marrow
- cell therapy
- open label
- patient reported
- smoking cessation